13F-HR filed by Deep Track Capital, LP
Deep Track Capital, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 13:55:03 UTC, with 74 holding rows worth $6,138,977,076.
- Accession
- 0001856083-26-000006
- Filer
- CIK 1856083
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 74 entries on the cover page, a total value of $6,138,977,076 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,138,977,076 with VALUE read as dollars as filed, 13F file number 028-21949. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 2,805,677 | $500,420,550 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 6,374,395 | $382,463,700 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 9,160,801 | $309,451,858 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 3,806,768 | $299,250,032 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 1,900,000 | $230,337,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 7,000,000 | $226,030,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 3,513,069 | $199,893,626 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 4,500,000 | $182,340,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 21,939,625 | $168,276,924 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 300,040 | $162,588,676 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 5,000,000 | $156,350,000 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 1,104,200 | $154,720,504 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 1,350,000 | $154,089,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 12,161,496 | $151,289,010 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 4,182,689 | $149,217,430 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 800,000 | $147,512,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 6,000,000 | $142,260,000 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 3,352,804 | $128,680,617 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 4,500,000 | $112,275,000 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 4,083,969 | $111,002,277 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 3,587,796 | $110,647,629 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 2,760,000 | $98,463,000 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 8,105,290 | $94,831,893 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 1,069,774 | $89,101,476 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 1,200,000 | $86,760,000 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 1,000,000 | $81,900,000 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,500,000 | $80,050,000 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 3,333,334 | $78,266,682 | dollars as filed | |
| BICARA THERAPEUTICS INC | 055477103 | COM | 4,100,000 | $76,301,000 | dollars as filed | |
| Latigo Biotherapeutics, Inc. | 517954103 | Common Stock, par value $0.0001 per share | 4,408,322 | $73,618,978 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,125,532 | $68,888,492 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 885,882 | $58,291,036 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 3,610,000 | $55,341,300 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 7,469,746 | $55,201,423 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 19,250,000 | $55,055,000 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 3,207,138 | $54,970,345 | dollars as filed | |
| BILLIONTOONE INC | 090168105 | CL A | 500,000 | $53,220,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 9,345,000 | $49,154,700 | dollars as filed | |
| CORMEDIX INC COM | 21900C308 | Stock | 6,274,076 | $48,310,385 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,148,817 | $46,641,970 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 5,740,850 | $46,213,843 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 1,000,000 | $38,060,000 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 2,507,449 | $37,661,884 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 640,000 | $37,516,800 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 500,000 | $36,325,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,711,030 | $35,230,108 | dollars as filed | |
| HARROW INC | 415858109 | COM | 1,069,000 | $32,925,200 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 2,120,050 | $29,108,287 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 2,491,939 | $28,707,137 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 200,000 | $28,368,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 3,565,062 | $25,775,398 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 3,706,734 | $25,279,926 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 1,000,000 | $24,450,000 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 5,030,522 | $19,619,036 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 500,000 | $18,595,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,109,951 | $18,229,977 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 300,000 | $18,163,500 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,323,986 | $16,642,504 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 9,462,645 | $16,181,123 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,000,000 | $16,110,000 | dollars as filed | call |
| XENCOR INC | 98401F105 | COMMON STOCK | 540,000 | $13,473,000 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 1,318,101 | $13,431,449 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,000,000 | $13,180,000 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 4,501,684 | $13,054,884 | dollars as filed | |
| KARDIGAN INC | 485925101 | CMN | 600,000 | $8,850,000 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 740,117 | $8,030,269 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 2,450,980 | $7,132,352 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 1,230,566 | $6,029,773 | dollars as filed | |
| RAINIER ACQUISITION CORP | G73591110 | UNIT | 500,000 | $5,100,000 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 450,000 | $4,959,000 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 400,000 | $4,628,000 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 300,000 | $3,753,000 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 444,110 | $2,500,339 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,419,355 | $2,228,774 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001856083-26-000006 | this filing | 2026-11-16 |